News

Owlytics Healthcare CEO Gill Zaphrir, on the Future of Multiple Sclerosis Clinical Research. The market is flooded with self-monitoring wearables, but not all wearables offer the same features [...]

Following the successful introduction of the validated analytics solution for a research study focused on Parkinson’s disease, Owlytics Healthcare, together with its research partner Tel-Aviv [...]

Owlytics Healthcare, in partnership with Tel-Aviv Medical Center in Israel, has taken its smartwatch — designed to monitor symptoms of multiple sclerosis (MS) from afar — through a first stage of [...]

Owlytics Healthcare and its research partner Tel-Aviv Medical Center have announced the 1st validation stage of MS metrics for the continuous remote monitoring and analytics solution to measure [...]

Aggressive treatment with these medications as early as possible can lower the relapse rate, slow the formation of new lesions, and potentially reduce risk of brain atrophy and disability accumulation

The novel coronavirus sent pharmaceutical companies racing to innovate new treatments and repurpose old ones, as the development of a vaccine continues. At the same time, we’re struggling to find [...]

Owlytics announced today, August 27, 2020, in Tel Aviv that the company has entered into a definitive service agreement with a global pharma vendor. The service will provide continuous motion and [...]

The SIM-based wearable monitors the health of senior citizens and detects falls after analyzing personal data.